Michael Andrews
Overview
Explore the profile of Michael Andrews including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allen-Philbey K, Stephenson S, Doody G, MacDougall A, Aboulwafaali M, Ammoscato F, et al.
Clin Exp Immunol
. 2024 Dec;
219(1).
PMID: 39663507
Introduction: Cladribine is a deoxyadenosine analogue that can penetrate the blood-brain barrier. It is used to treat multiple sclerosis (MS). However, the mechanistic understanding of the effect of this highly...
2.
Ammoscato F, Wafa M, Skonieczna J, Bestwick J, Monero R, Andrews M, et al.
Clin Immunol
. 2024 Oct;
269:110380.
PMID: 39428028
Recent studies demonstrate the efficacy of B cell-targeting therapies in managing multiple sclerosis (MS) activity, emphasizing the critical role of B cells in MS pathogenesis. CladB study aimed to quantify...
3.
Chakraborty A, Yang C, Kresak J, Silver A, Feier D, Tian G, et al.
Cells
. 2024 Jun;
13(11.
PMID: 38891070
Glioblastoma (GBM) poses a significant challenge in clinical oncology due to its aggressive nature, heterogeneity, and resistance to therapies. Cancer stem cells (CSCs) play a critical role in GBM, particularly...
4.
Chakraborty A, Yang C, Kresak J, Silver A, Feier D, Tian G, et al.
bioRxiv
. 2024 Mar;
PMID: 38501121
Glioblastoma (GBM) poses a significant challenge in clinical oncology due to its aggressive nature, heterogeneity, and resistance to therapies. Cancer stem cells (CSCs) play a critical role in GBM, particularly...
5.
Andrews M, Gao H, Datta S, Katz J
Clin Oral Investig
. 2023 Aug;
27(10):5925-5933.
PMID: 37606722
Objectives: Periodontal disease has been linked to multiple systemic conditions, but the relationship with COVID-19 still needs to be elucidated. We hypothesized that periodontal disease may be associated with COVID-19...
6.
Ivanova A, Rees J, Parks B, Andrews M, Gardner M, Grigorutsa E, et al.
Biomolecules
. 2022 Oct;
12(10).
PMID: 36291648
Aberrations in lipid and lipoprotein metabolic pathways can lead to numerous diseases, including cardiovascular disease, diabetes, neurological disorders, and cancer. The integration of quantitative lipid and lipoprotein profiling of human...
7.
Andrews M, Yoshida T, Henderson C, Pflaum H, McGregor A, Lieberman J, et al.
PLoS One
. 2022 Oct;
17(10):e0276649.
PMID: 36279295
Background: Genetic variants in apolipoprotein L1 (APOL1), a protein that protects humans from infection with African trypanosomes, explain a substantial proportion of the excess risk of chronic kidney disease affecting...
8.
Mahler C, Andrews M, Henson S, Gnanapavan S
Neurol Neuroimmunol Neuroinflamm
. 2020 May;
7(4).
PMID: 32434801
No abstract available.
9.
Ma H, Hayama T, Van Dyken C, Darby H, Koski A, Lee Y, et al.
Biol Reprod
. 2019 Oct;
102(3):607-619.
PMID: 31621839
Heritable mitochondrial DNA (mtDNA) mutations are common, yet only a few recurring pathogenic mtDNA variants account for the majority of known familial cases in humans. Purifying selection in the female...
10.
Andrews M, Iqbal J, Wall J, Teare D, El-Omar M, Fath-Ordoubadi F, et al.
Cardiovasc Revasc Med
. 2019 Feb;
20(11):980-984.
PMID: 30773426
Background: Primary percutaneous coronary intervention (PPCI) is the default treatment for patients with ST elevation myocardial infarction (STEMI) and carries a higher risk of adverse outcomes when compared with elective...